Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN115385948B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115385948B introduces novel spiro-bisoxazoline ligands offering superior enantioselectivity and simplified synthesis for reliable pharmaceutical intermediates supply chains.